DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Maccecchini ML, Chang MY, Pan C, John V, Zetterberg H, Greig NH.
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans.
J Neurol Neurosurg Psychiatry 2012;
83 (09) 894-902
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.